Craig Jalbert

Craig Jalbert

Vorstandsvorsitzender bei CARISMA THERAPEUTICS, INC.
64 Jahre
Health Technology
Electronic Technology
Commercial Services

Profil

Craig R.
Jalbert
currently serves as President, CEO, CFO, Secretary, Treasurer, Director, and CAO in multiple companies including Carisma Therapeutics, Inc. (since 2026), Unity Biotechnology, Inc. (since 2025), Evelo Biosciences, Inc. (since 2023), eFFECTOR Therapeutics, Inc. (since 2024), TRACON Pharmaceuticals, Inc. (since 2024), NexImmune, Inc. (since 2024), TFF Pharmaceuticals, Inc. (since 2024), Better Therapeutics, Inc. (since 2025), T2 Biosystems, Inc. (since 2025), Rubius Therapeutics, Inc. (since 2023), and holds director roles at CohBar, Inc. (since 2023).
Also holds leadership roles at Seaside Therapeutics LLC, Mitralign, Inc., Avenge Bio, Inc., Aerami Therapeutics Holdings, Inc., and has been Principal at Verdolino & Lowey PC since 1987.
Former roles include Chief Executive Officer, CFO, and Director at Agritech Worldwide, Inc.; President, CEO, CFO, Secretary, Treasurer, and CAO at MZT Holdings, Inc. from 2010 to 2012; President, CEO, Secretary, Treasurer, and Director at Axcella Health, Inc., Molecular Templates, Inc., Bellerophon Therapeutics, Inc., Viracta Therapeutics, Inc., Cambridge Heart, Inc., Dendreon Corp., SIONEX Corp., and CompuCyte Corp.; President, Secretary, Treasurer, and Director at Fetco Home Decor, Inc. and Matritech, Inc.; President, Secretary, Treasurer, and Director at Aptinyx, Inc. in 2023; Director at Oncorus, Inc. in 2023; and President, Secretary, and Treasurer at Ibis Technology Corp.
from 2009 to 2012.

Aktive Positionen von Craig Jalbert

UnternehmenPositionBeginn
RUBIUS THERAPEUTICS Präsident 04.03.2023
COHBAR Direktor/Vorstandsmitglied 06.11.2023
EVELO BIOSCIENCES, INC. Vorstandsvorsitzender 21.11.2023
BETTER THERAPEUTICS, INC. Vorstandsvorsitzender 14.03.2025
EFFECTOR THERAPEUTICS, INC. Vorstandsvorsitzender 21.06.2024
TRACON PHARMACEUTICALS, INC. Vorstandsvorsitzender 31.07.2024
NEXIMMUNE, INC. Vorstandsvorsitzender 27.08.2024
TFF PHARMACEUTICALS, INC. Vorstandsvorsitzender 14.11.2024
T2 BIOSYSTEMS, INC. Vorstandsvorsitzender 03.04.2025
░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░ -

Ehemalige bekannte Positionen von Craig Jalbert

UnternehmenPositionEnde
░░░░ ░░░░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░░ -
░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░ -
░░░░░░░░░ ░░░░░ ░░░░░░░░░░ -
Sehen Sie sich die Erfahrung von Craig Jalbert im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

51

Beziehungen ersten Grades

31

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen31

Health Technology

Electronic Technology

Health Technology

Consumer Non-Durables

Health Technology

Electronic Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Durables

Health Technology

Health Technology

Distribution Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Craig Jalbert